Using molecular engineering and artificial intelligence, RevolKa designs reliable and quick solutions for the healthcare sector. By creating a map of sequence space and climbing a mountain of sequences with a purpose solution, the company offers molecularly engineered bioproducts and antibody drugs. Founded in 2021 and based in Tokyo, Japan, RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.